Table 1.
Corneal subbasal nerve density in patients (mm/mm2) | Corneal subbasal nerve density in controls (mm/mm2) | |
---|---|---|
Diabetes type 1 [14] | 20.6 ± 1.5 | 27.7 ± 1.1 |
Diabetes type 2 [24] | 4.3 ± 1.5 | 13.5 ± 0.3 |
Parkinson's disease [32] | 15.0 ± 8.0 | 13.5 ± 5.0 |
Progressive supranuclear palsy [32] | 15.0 ± 6.0 | 13.5 ± 5.0 |
Amyotrophic lateral sclerosis [36] | 1.8 ± 0.4 | 2.3 ± 0.4 |
Idiopathic small fibre neuropathy [38] | 4.4 ± 0.6 | 9.3 ± 0.6 |
Charcot-Marie-Tooth type 1A [41] | 15.8 ± 1.5 | 26.7 ± 1.3 |
Chronic inflammatory demyelinating polyneuropathy [62] | 18.1 ± 3.4 | 23.5 ± 3.6 |
Chemotherapy induced peripheral neuropathy [9] | 6.8 ± 2.4 | 10.8 ± 3.8 |